Clinical Study

High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Recurrent or Refractory Hodgkin's Lymphoma: Analysis of King Hussein Cancer Center Results and Prognostic Variables

Table 2


Summary statistics
 Total observed63
 Total failed13
 Total censored50

Mean survival time
 Mean survival time (survival < 40.9)32.550
 Standard deviation2.070
 Lower bound (95%)28.492
 Upper bound (95%)36.608

Quantiles estimation
 Quantile50%
 Estimate40.600
 Lower bound (95%)27.500
 Upper bound (95%)